Retraction Note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth Authors: Juan Li, Jie Liu, Zheyong Liang, Fang He, Lu Yang, Pingping Li, Yina Jiang, Bo Wang, Can Zhou, Yaochun Wang, Yu Ren, Jin Yang, Jianmin Zhang, Zhijun Luo, Cyrus Vaziri, Peijun Liu Published: 2025 Retraction Note to: Cell Death and Disease 10.1038/cddis.2017.46, published online 16 March 2017 The Editors-in-Chief have retracted this article. Image integrity concerns were found within figure 1, between figures 1 and 2, between figures 2 and 3, and between figures 3 and 4. The images provided by the authors were not sufficient to resolve the concerns. The Editors have lost confidence in the data which supports the conclusions of the article. Authors Juan Li and Peijun Liu disagree with this retraction. All other authors have not responded to the publisher regarding this retraction.